Skip to main content

News

Latest News

May 16, 2016
Washington, D.C.  – On Tuesday, May 17, 2016 at 10:00 a.m., the Crime, Terrorism, Homeland Security, and Investigations Subcommittee will hold a hearing to examine the growing problem of synthetic drugs in the United States, including those sold commercially. Designer synthetic drugs are often marketed as herbal incense, bath salts, jewelry cleaner, or plant food, and have caused significant abuse, addiction, emergency room visits, and even fatalities.
May 16, 2016
Washington, D.C.  – On Tuesday, May 17, 2016 at 10:00 a.m., the Crime, Terrorism, Homeland Security, and Investigations Subcommittee will hold a hearing to examine the growing problem of synthetic drugs in the United States, including those sold commercially. Designer synthetic drugs are often marketed as herbal incense, bath salts, jewelry cleaner, or plant food, and have caused significant abuse, addiction, emergency room visits, and even fatalities.
May 13, 2016
Washington, D.C. – The House Judiciary Committee has announced its schedule for the week of May 16-20, 2016. TUESDAY, MAY 1710:00 a.m. | Subcommittee on Crime, Terrorism, Homeland Security, and InvestigationsHearing on: “Synthetic Drugs, Real Danger” Witnesses:
  • Mr. Louis J. Milione, Deputy Assistant Administrator, U.S. Drug Enforcement Administration
  • Mr. William Smith, Jr., Officer, Washington, D.C.
May 13, 2016
Washington, D.C.  – The House Judiciary Committee today announced that it will hold two full committee hearings to examine misconduct by the Internal Revenue Service (IRS) Commissioner John Koskinen. At the first hearing, which will take place on Tuesday, May 24 at 10:00 a.m., members of the House Judiciary Committee will hear from a witness panel presenting the findings of the House Oversight and Government Reform Committee’s investigation of IRS Commissioner Koskinen. The House Judiciary Committee will also invite IRS Commissioner Koskinen to testify.
May 13, 2016
Washington, D.C.  – House Judiciary Committee Chairman Bob Goodlatte (R-Va.) issued the statement below after the House of Representatives voted to amend the Comprehensive Addiction and Recovery Act (S. 524): “This week, the House took bold and decisive action to address America’s opioid crisis. No community is immune from this epidemic and all too often we hear of people losing their lives to these drugs.
May 13, 2016
Washington, D.C.  – House Judiciary Committee Chairman Bob Goodlatte (R-Va.) issued the statement below after the House of Representatives voted to amend the Comprehensive Addiction and Recovery Act (S. 524): “This week, the House took bold and decisive action to address America’s opioid crisis. No community is immune from this epidemic and all too often we hear of people losing their lives to these drugs.
May 12, 2016
Washington, D.C.  – The House of Representatives today approved by a vote of 413-5 the Comprehensive Opioid Abuse Reduction Act (H.R. 5046).
May 12, 2016
Washington, D.C.  – The House of Representatives today approved by a vote of 413-5 the Comprehensive Opioid Abuse Reduction Act (H.R. 5046).
May 12, 2016
Washington, D.C.  – House Judiciary Committee Chairman Bob Goodlatte (R-Va.) issued the statement below on the United States District Court for the District of Columbia’s ruling in favor of the House of Representative’s lawsuit challenging the Obama Administration’s use of unappropriated funds to implement the Affordable Care Act.
Chairman Goodlatte: “Today’s ruling by the DC federal court is an important step toward restoring the sepa